Trancura Biosciences

Emeryville, United States

Trancura Biosciences is a biotechnology company that uses targeted genomic approaches for the de nov design of monoclonal antibodies.

$972K raised

Jan 2022

Seed

Biotechnology Life Science Medical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Trancura Biosciences

How much funding has Trancura Biosciences raised?

Trancura Biosciences has raised $972K in total funding. The most recent round was Seed. The last funding was announced in January 2022.

Where is Trancura Biosciences headquartered?

Trancura Biosciences is headquartered in Emeryville, United States.

What does Trancura Biosciences do?

Trancura Biosciences is a biotechnology company that uses targeted genomic approaches for the de nov design of monoclonal antibodies.

What stage is Trancura Biosciences at?

Trancura Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2022.

MLA

"Trancura Biosciences — Funding & Investors." VCBacked, January 7, 2022, https://www.vcbacked.co/company/trancura-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2022). Trancura Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/trancura-biosciences

Wikipedia (cite web)

{{cite web |title=Trancura Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/trancura-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K